Release and Cytocompatibility Study of New Hybrid Materials Based on Ferulic Acid for Biomedical Use

In recent years, research into the synthesis of innovative biomaterials for prosthetic applications has been increasingly growing. In particular, there is a demand for biomaterials with an excellent biocompatibility that can interact with biological fluids. This study involved the development of new silica (SiO2)-based composite materials using the sol–gel technique and functionalization with ferulic acid (FA), a natural phenolic compound renowned for its biological properties. The synthesis involved controlling the hydrolysis and condensation of tetraethyl orthosilicate (TEOS) in acidic and alcoholic environments to incorporate ferulic acid into the sol phase matrix at different weight compositions (5, 10, 15, and 20 wt%). Fourier transform infrared spectroscopy analyses (FTIR) confirmed the successful incorporation of the bioactive compound, and in vitro tests revealed a good cytocompatibility and controlled ferulic acid release over time. These results demonstrate that the developed material shows promise as a bioactive coating for orthopedic prostheses, improving bone integration and reducing undesirable post-operative phenomena.